Drugs / Modified Suan ZaoRen Tang-TianWang BuXin Dan
Modified Suan ZaoRen Tang-TianWang BuXin Dan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06511011 | Sep 2024 → May 2026 overdue | insomnia | Chinese University of Hong Kong | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modified Suan ZaoRen Tang-TianWang BuXin Dan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06511011 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese medicine granules” NCT06511011 ↗ |